Affiliation: University of British Columbia
- Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policyBarbara Mintzes
Centre for Health Services and Policy Research, University of British Columbia UBC, Vancouver, BC Canada V6T 1Z3
Res Social Adm Pharm 1:310-30. 2005..This article describes a survey of Canadian drug policy experts carried out in 2001, during one such legislative review. The survey results are compared to more recent DTCA policy developments...
- Pfizer conducts survey of French patients on information provided by industryBarbara Mintzes
BMJ 334:1027. 2007
- Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary taleBarbara Mintzes
Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada Barbara Mintzes
PLoS ONE 4:e5699. 2009..We ask how annual per capita spending compares to that in the US, and whether drugs with Canadian or US regulatory safety warnings are advertised to the Canadian public in reminder advertising...
- Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional surveyBarbara Mintzes
Centre for Health Services and Policy Research, University of British Columbia, Vancouver BC, Canada V6T 1Z3
BMJ 324:278-9. 2002
- Should patient groups accept money from drug companies? NoBarbara Mintzes
Therapeutics Initiative and Health Action International HAI Europe, 2176 Health Sciences Mall, Vancouver BC, V6T 1Z3 Canada
BMJ 334:935. 2007
- Disease mongering in drug promotion: do governments have a regulatory role?Barbara Mintzes
Therapeutics Initiative, Department of Anaesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada
PLoS Med 3:e198. 2006
- How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCABarbara Mintzes
Centre for Health Services and Policy Research, and the Department of Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC
CMAJ 169:405-12. 2003..We compared prescribing decisions in a US setting with legal DTCA and a Canadian setting where DTCA of prescription drugs is illegal, but some cross-border exposure occurs...
- For and against: Direct to consumer advertising is medicalising normal human experience: ForBarbara Mintzes
Centre for Health Services and Policy Research, University of British Columbia, 429 2194 Health Services Mall, Vancouver, BC, Canada V6T 1Z3
BMJ 324:908-9. 2002
- An outcomes-based approach to decisions about drug coverage policies in British ColumbiaSteve Morgan
Program in Pharmaceutical Policy, Centre for Health Services and Policy Research, University of British Columbia, 429 2194 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3
Psychiatr Serv 55:1230-2. 2004
- The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?Steven Morgan
Centre for Health Services and Policy Research, University of British Columbia, 429 2194 Health Sciences Mall, Vancouver, V6T 1Z3, Canada
J Health Serv Res Policy 8:237-44. 2003....
- Medicine by media: did a critical television documentary affect the prescribing of cyproterone--estradiol (Diane-35)?Barbara Mintzes
Centre for Health Services and Policy Research, University of British Columbia, Vancouver, BC
CMAJ 173:1313-5. 2005
- Pharmaceutical sales representatives and patient safety: a comparative prospective study of information quality in Canada, France and the United StatesBarbara Mintzes
School of Population and Public Health, University of British Columbia, 307, 2176 Health Sciences Mall, Vancouver, British Columbia, V6T 1Z3, Canada
J Gen Intern Med 28:1368-75. 2013..The United States (US) and France directly regulate drug promotion; Canada relies on industry self-regulation. France has the strictest information standards...
- Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006)Jamie R Daw
Centre for Health Services and Policy Research, School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada
Clin Ther 34:239-249.e2. 2012..Owing to the paucity of evidence available on the risks and benefits of drug use in pregnancy, the use of prescription medicines is a concern for both pregnant women and their health care providers...
- Outcomes-based drug coverage in British ColumbiaSteven Morgan
University of British Columbia, Health Care and Epidemiology, Program in Pharmaceutical Policy, Centre for Health Services and Policy Research
Health Aff (Millwood) 23:269-76. 2004..We describe lessons from the B.C. experience for jurisdictions interested in basing coverage on evidence of proven comparative advantage for patients' health...
- Advertising of prescription-only medicines to the public: does evidence of benefit counterbalance harm?Barbara Mintzes
Therapeutics Initiative, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada
Annu Rev Public Health 33:259-77. 2012..There is no evidence of improved treatment quality or early provision of needed care. If policy is to be informed by evidence, the strength of research methods and ability to assess causality need to be considered...
- The sources and popularity of online drug information: an analysis of top search engine results and web page viewsMichael R Law
Centre for Health Services and Policy Research, School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada
Ann Pharmacother 45:350-6. 2011..The Internet has become a popular source of health information. However, there is little information on what drug information and which Web sites are being searched...
- Direct-to-consumer advertising of prescription medicines: a counter argumentBarbara Mintzes
Therapeutics Initiative, University of British Columbia, 2176 Health Services Mall, Vancouver, BC, V6T 1Z3, Canada
Future Med Chem 1:1555-60. 2009..b>Barbara Mintzes and Dee Mangin provide their case against direct-to-consumer advertising of prescription medicines, arguing ..
- Too much disclosure of product risks? CBC television, SOGC, and Diane-35Barbara Mintzes
Centre for Health Services and Policy Research, University of British Columbia, Vancouver, BC, Canada
J Obstet Gynaecol Can 25:268-9; discussion 270-3. 2003
- Medicine reimbursement recommendations in Canada, Australia, and ScotlandJoel Lexchin
School of Health Policy and Management, York University, 4700 Keele St, Toronto, Ontario, Canada M3J 1P3
Am J Manag Care 14:581-8. 2008....
- Direct to consumer advertising of prescription drugsBarbara Mintzes
BMJ 337:a985. 2008
- Direct-to-consumer prescription drug advertising in Canada: permission by default?David M Gardner
Department of Psychiatry and the College of Pharmacy, Dalhousie University, Halifax, NS
CMAJ 169:425-7. 2003
- Do higher drug costs lead to better health?Barbara Mintzes
Can J Clin Pharmacol 12:e22-7. 2005..For "newer" to truly mean "better", fundamental changes are needed to the regulations governing market approval and post-approval surveillance. Such changes are possible, but would require strong political will...
- Direct-to-consumer advertising is more profitable if it is misleadingPeter R Mansfield
Director, Healthy Skepticism, Willunga, SA, Australia
N Z Med J 116:U610. 2003
- Transparency in drug regulation: mirage or oasis?Joel Lexchin
Emergency Department, University Health Network, School of Health Policy and Management, York University, Toronto, Ont
CMAJ 171:1363-5. 2004
- Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugsAlan Cassels
School of Health Information Science, University of Victoria, Victoria, BC
CMAJ 168:1133-7. 2003..We assessed newspaper descriptions of drug benefits and harms, the nature of the effects described and the presence or absence of other important information that can add context and balance to a report about a new drug...
- Antidepressants and adverse effects in young patients: uncovering the evidenceAndrew Herxheimer
Cochrane Collaboration, London, England
CMAJ 170:487-9. 2004
- Direct to consumer advertisingPeter R Mansfield
BMJ 330:5-6. 2005
- Should paroxetine be used to treat depression during pregnancy?Barbara Mintzes
Am J Psychiatry 165:1487; author reply 1487-8. 2008
- Questions about Adderall XRPierre Biron
CMAJ 174:1303-4. 2006
- Does direct-to-consumer advertising of antidepressants lead to a net social benefit?Jon Jureidini
Women s and Children s Hospital, North Adelaide, SA, Australia
Pharmacoeconomics 26:557-66; discussion 567-8. 2008
- Medications for obesityJoel Lexchin
Can Fam Physician 54:848-9; author reply 849-50. 2008
- Drug safety without borders: concerns about bupropionBarbara Mintzes
CMAJ 167:447. 2002